• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients.与慢性血液透析患者血管和瓣膜钙化相关的生物标志物。
Dis Markers. 2013;34(4):229-35. doi: 10.3233/DMA-130965.
2
Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.血液透析患者的血管钙化与血清胎球蛋白-A 和骨桥蛋白水平无关。
Int Urol Nephrol. 2018 Jan;50(1):137-142. doi: 10.1007/s11255-017-1740-6. Epub 2017 Nov 13.
3
Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients.骨保护素在终末期肾病患者血管疾病中的作用。
Biomarkers. 2015 Mar;20(2):116-22. doi: 10.3109/1354750X.2014.1000376. Epub 2015 Jan 14.
4
Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice?血液透析患者的血管钙化与动脉粥样硬化:我们能从常规临床实践中学到什么?
Int Urol Nephrol. 2008;40(3):763-70. doi: 10.1007/s11255-008-9379-y. Epub 2008 Jun 27.
5
Comparison of fetuin-A, vitamin D, monounsaturated fatty acid, and vascular calcification on plain radiography between dialysis modalities.透析方式之间胎球蛋白-A、维生素D、单不饱和脂肪酸与平片上血管钙化情况的比较。
Iran J Kidney Dis. 2013 Nov;7(6):453-60.
6
Vascular calcification in Mexican hemodialysis patients.墨西哥血液透析患者的血管钙化。
Arch Med Res. 2013 Nov;44(8):628-32. doi: 10.1016/j.arcmed.2013.10.018. Epub 2013 Nov 8.
7
Factors associated with various arterial calcifications in haemodialysis patients.血液透析患者各种动脉钙化的相关因素。
Prilozi. 2008 Dec;29(2):185-199.
8
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study.接受透析的中国患者血管钙化的患病率和危险因素:一项前瞻性队列研究的基线结果。
Curr Med Res Opin. 2018 Aug;34(8):1491-1500. doi: 10.1080/03007995.2018.1467886. Epub 2018 May 3.
9
Screening of vascular calcifications in patients with end-stage renal diseases.终末期肾病患者血管钙化的筛查
Gen Physiol Biophys. 2009;28 Spec No:277-83.
10
C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis.在接受长期血液透析的非糖尿病终末期肾病患者中,C反应蛋白水平与动脉中层钙化相关。
Clin Nephrol. 2011 Dec;76(6):425-34. doi: 10.5414/cn107003.

引用本文的文献

1
Association between the serum uric acid-to-creatinine ratio and cardiovascular mortality in maintenance hemodialysis patients.维持性血液透析患者血清尿酸与肌酐比值与心血管死亡率的关系。
Ren Fail. 2025 Dec;47(1):2509787. doi: 10.1080/0886022X.2025.2509787. Epub 2025 May 25.
2
The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes.在一项针对2型糖尿病患者的10年纵向研究中骨保护素与动脉僵硬度之间的关联。
Diab Vasc Dis Res. 2024 Nov-Dec;21(6):14791641241304435. doi: 10.1177/14791641241304435.
3
The Relationship of Fetuin-A with Coronary Calcification, Carotid Atherosclerosis, and Mortality Risk in Non-Dialysis Chronic Kidney Disease.非透析慢性肾脏病中胎球蛋白-A与冠状动脉钙化、颈动脉粥样硬化及死亡风险的关系
J Lipid Atheroscler. 2024 May;13(2):194-211. doi: 10.12997/jla.2024.13.2.194. Epub 2024 Mar 7.
4
Uremic mouse model to study vascular calcification and "inflamm-aging".用于研究血管钙化和“炎老化”的尿毒症小鼠模型。
J Mol Med (Berl). 2022 Sep;100(9):1321-1330. doi: 10.1007/s00109-022-02234-y. Epub 2022 Aug 2.
5
High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients.高C末端成纤维细胞生长因子-23、完整甲状旁腺激素和白细胞介素-6作为维持性血液透析患者瓣膜钙化的决定因素
Int J Gen Med. 2022 Apr 20;15:4227-4236. doi: 10.2147/IJGM.S359168. eCollection 2022.
6
The Role of Interleukin-6 Family Members in Cardiovascular Diseases.白细胞介素-6家族成员在心血管疾病中的作用
Front Cardiovasc Med. 2022 Mar 23;9:818890. doi: 10.3389/fcvm.2022.818890. eCollection 2022.
7
IL-6 Is Associated with Progression of Coronary Artery Calcification and Mortality in Incident Dialysis Patients.白细胞介素-6 与新发透析患者冠状动脉钙化进展和死亡率相关。
Am J Nephrol. 2021;52(9):745-752. doi: 10.1159/000518652. Epub 2021 Sep 15.
8
Association of Serum Uric Acid Concentration and Its Change with Cardiovascular Death and All-Cause Mortality.血清尿酸浓度及其变化与心血管死亡和全因死亡率的关系。
Dis Markers. 2020 Jan 28;2020:7646384. doi: 10.1155/2020/7646384. eCollection 2020.
9
New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.单核细胞/巨噬细胞在与慢性肾脏病相关的心血管钙化中作用的新见解
Toxins (Basel). 2019 Sep 12;11(9):529. doi: 10.3390/toxins11090529.
10
The role of uric acid in mineral bone disorders in chronic kidney disease.尿酸在慢性肾脏病矿物质和骨代谢紊乱中的作用。
J Nephrol. 2019 Oct;32(5):709-717. doi: 10.1007/s40620-019-00615-0. Epub 2019 Apr 27.

与慢性血液透析患者血管和瓣膜钙化相关的生物标志物。

Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients.

机构信息

Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Dis Markers. 2013;34(4):229-35. doi: 10.3233/DMA-130965.

DOI:10.3233/DMA-130965
PMID:23396289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3810241/
Abstract

BACKGROUND

Cardiovascular calcification, including arterial intimal and medial calcification (AIC and AMC) and valvular calcification (VC) are important predictors of outcome in chronic dialysis patients. We aimed to compare their prevalence and analyze respective risk factors in hemodialysis (HD) patients.

METHODS

A total of 81 HD patients were enrolled. Vascular calcification was assessed by plain film radiography of the pelvis and VC was diagnosed by echocardiography. Demographic data was reviewed and serum levels of calcification-relevant biomarkers were determined. Patients with and without calcification were then compared.

RESULTS

The prevalence study indicated that 36 patients had AIC (44.4%), 17 had AMC (21%) and 60 (74.1%) had VC. Patients with vascular calcification were older, and had a higher prevalence of diabetes. Their IL-6, osteoprotegerin, and uric acid levels were higher. Serum fetuin-A was lower in patients with VC. Logistic regression analysis revealed age, uric acid and diabetes to be independently associated with AIC; uric acid, diabetes and osteoprotegerin with AMC. Fetuin-A was the sole associate of VC.

CONCLUSIONS

It is concluded that the prevalence of cardiovascular calcification in chronic HD patients was high with cardiac valve involvement more frequent. Factors associated with different type of calcification were not identical. Changes in biomarkers may represent clinical clues for assessment of cardiovascular calcification in HD patients.

摘要

背景

心血管钙化,包括动脉内膜和中膜钙化(AIC 和 AMC)和瓣膜钙化(VC),是慢性透析患者预后的重要预测因素。我们旨在比较血液透析(HD)患者中它们的患病率,并分析各自的危险因素。

方法

共纳入 81 名 HD 患者。通过骨盆的平片评估血管钙化,通过超声心动图诊断 VC。回顾了人口统计学数据,并测定了钙化相关生物标志物的血清水平。然后比较有和没有钙化的患者。

结果

患病率研究表明,36 名患者有 AIC(44.4%),17 名有 AMC(21%),60 名(74.1%)有 VC。有血管钙化的患者年龄较大,且糖尿病的患病率较高。他们的 IL-6、骨保护素和尿酸水平较高。VC 患者的血清胎球蛋白 A 较低。Logistic 回归分析显示年龄、尿酸和糖尿病与 AIC 独立相关;尿酸、糖尿病和骨保护素与 AMC 相关。胎球蛋白 A 是 VC 的唯一相关因素。

结论

总之,慢性 HD 患者心血管钙化的患病率较高,且心脏瓣膜受累更为常见。与不同类型钙化相关的因素并不相同。生物标志物的变化可能代表了评估 HD 患者心血管钙化的临床线索。